Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw An institutional inquiry

Journal of the American Dental Association

Volumn 140, Issue 1, 2009, Pages 61-66

  Sedghizadeh, Parish P ^a,c   Stanley, Kyle ^a   Caligluri, Matthew ^a   Hofkes, Shawn ^a   Lowry, Brad ^a   Shuler, Charles F ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c Office 4110 A   (United States)

Author keywords

Alendronate; Extraction; Jaw; Oral bisphosphonates; Osteonecrosis

Indexed keywords

EID: 58249101479     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2009.0019     Document Type: Article

References (18)

1. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002;32(2):94-124.
2. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;102(4):433-441.
3. Epstein S. Update of current therapeutic options for the treatment of postmenopausal osteoporosis. Clin Ther 2006;28(2)-.151-173.
4. Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol 2006;24(6):945-952.
5. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62(5):527-534.
6. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 2007;65(3):415-423.
7. Mönkkönen H, Auriola S, Lehenkari P, et al. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogencontaining bisphosphonates. Br J Pharmacol 2006; 147(4):437-445.
8. Ensrud KE, Barrett-Connor EL, Schwartz A, et al. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension. J Bone Miner Res 2004;19(8).1259-1269.
9. Migliorati CA, Siegel MA, Elting LS. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. Lancet Oncol 2006;7(7):508-514.
10. American Dental Association Council on Scientific Affairs. Dental management of patients receiving oral bisphosphonate therapy: expert panel recommendations. JADA 2006;137(8):1144-1150.
11. Edwards BJ, Hellstein JW, Jacobsen PL, Kaltman S, Mariotti A, Migliorati CA; for the American Dental Association Council on Scientific Affairs Expert Panel on Bisphosphonate-Associated Osteonecrosis of the Jaw. Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. JADA 2008;139(12):1674-1677.
12. Kumar SK, Meru M, Sedghizadeh PP. Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series. J Contemp Dent Pract 2008;9(1):63-69.
13. National Osteoporosis Foundation. Fast facts on osteoporosis. "www.nof.org/osteoporosis/diseasefacts.htm". Accessed Oct. 16, 2007.
14. IMS reports U.S. prescription sales jump 8.3 percent in 2006, to $274.9 billion (press release). Norwalk, Conn.: IMS Health; March 8, 2007. "www.imshealth.com/portal/site/imshealth/menuitem. a46c6d4df3db4b3d88f611019418c22a/?vgnextoid=275bld3be7a29110Vg nVCM10000071812ca2RCRD & vgnextchannel= 41a67900b55a5110VgnVCM10000071812ca2RCRD & vgnextfmt=default". Accessed Nov. 14, 2007.
15. Bilezikian JP. Osteonecrosis of the jaw: do bisphosphonates pose a risk? N Engl J Med 2006;355(22):2278-2281.
16. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonateinduced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63(11):1567-1575.
17. Sedghizadeh PP, Kumar SK, Gorur A, Schaudinn C, Shuler CF, Costerton JW. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg 2008;66(4):767-775.
18. ADA Council on Scientific Affairs. Expert Panel Recommendations: Dental Management of Patients on Oral Bisphosphonate Therapy, "www.ada.org/prof/ resources/topics/topics-osteonecrosis-consent.pdf". Accessed Dec. 9, 2008.